Product image of Leuprorelin Zentiva (Leuprorelin Acetate) supplied by GNH India

Leuprorelin Zentiva

Active Ingredient:
Leuprorelin Acetate
Origin:
EU

Leuprorelin Zentiva (Leuprorelin Acetate)

Leuprorelin Acetate, the active ingredient in Leuprorelin Zentiva, is a Gonadotropin‑releasing hormone (GnRH) agonist presented as a subcutaneous injection for use in hormone‑dependent conditions. It is employed to suppress sex hormone production in patients with prostate cancer, endometriosis, uterine fibroids, central precocious puberty, and in assisted reproductive technology protocols.

GNH India supplies Leuprorelin Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Zentiva Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Leuprorelin Zentiva, a GnRH agonist, is used to manage hormone‑dependent conditions by reducing sex hormone levels.

  • Prostate cancer: reduces testosterone to slow tumor growth.
  • Endometriosis: lowers estrogen to alleviate pelvic pain and lesion progression.
  • Uterine fibroids: suppresses estrogen to shrink fibroid size and improve symptoms.
  • Central precocious puberty: halts premature activation of the hypothalamic‑pituitary‑gonadal axis.
  • Assisted reproductive technology: provides controlled ovarian suppression for timed stimulation protocols.

How It Works

  • Leuprorelin acetate is a synthetic analogue of GnRH that binds with high affinity to pituitary GnRH receptors. Initial binding causes a transient surge in luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) release, followed by receptor desensitization and down‑regulation, leading to markedly reduced LH and FSH secretion and consequent suppression of downstream sex steroid production (testosterone and estrogen).

Side Effects

Leuprorelin Zentiva may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects

  • Hot flashes: transient warmth and sweating.
  • Injection site reactions: pain, redness or swelling.
  • Headache: mild to moderate.
  • Fatigue: general tiredness.

Serious or Rare Side Effects

  • Cardiovascular events: hypertension or myocardial infarction.
  • Bone density loss: risk of osteoporosis or fractures.
  • Severe allergic reaction: anaphylaxis, rash or angioedema.

Precautions & Warnings

When prescribing Leuprorelin Zentiva, clinicians should consider several precautionary measures to ensure safe use.

  • Cardiovascular assessment: evaluate history of heart disease before initiating therapy.
  • Bone health monitoring: perform baseline densitometry and consider calcium/vitamin D supplementation.
  • Diabetes screening: monitor glucose levels as GnRH agonists may affect insulin sensitivity.
  • Pregnancy and lactation: avoid use in women who are pregnant or breastfeeding.
  • Hormonal flare management: anticipate an initial surge in sex hormones and consider short‑term anti‑androgen or estrogen blockade.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light, and do not freeze.

Avoid Interactions

Leuprorelin Zentiva can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Anti‑androgens or estrogen blockers: concurrent use may mask hormonal flare but requires careful coordination.
  • CYP enzyme modulators: strong inducers or inhibitors of CYP3A4 may alter drug metabolism; caution advised.

Moderate Interactions (Monitor Closely)

  • Anticoagulants: hormonal changes can affect clotting risk; monitor INR or coagulation parameters.
  • Bisphosphonates: concurrent bone‑protective therapy may be needed when long‑term GnRH agonist use is planned.
  • Antidepressants: mood alterations may be potentiated; observe psychiatric status.

Frequently Asked Questions

Leuprorelin Zentiva is indicated for hormone‑dependent diseases such as prostate cancer, endometriosis, uterine fibroids, central precocious puberty, and for controlled ovarian suppression in assisted reproductive technology protocols.

Leuprorelin Acetate mimics natural GnRH, binding to pituitary GnRH receptors. After an initial hormone surge, it desensitizes the receptors, leading to a sustained drop in luteinizing hormone and follicle‑stimulating hormone, which in turn suppresses the production of sex steroids like testosterone and estrogen.

The specific dose and dosing schedule of Leuprorelin Zentiva are determined by the prescribing clinician based on the patient’s condition, weight, and treatment goals. Dosing information is provided in the product’s prescribing information and should not be altered without medical guidance.

Leuprorelin Zentiva is generally contraindicated in pregnant or breastfeeding women because it suppresses sex hormone production, which can affect fetal development and milk production. Women of child‑bearing potential should use effective contraception during treatment.

To place an order, submit an enquiry on the Leuprorelin Zentiva product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Leuprorelin Zentiva is a synthetic GnRH agonist with a pharmacokinetic profile comparable to other agents such as goserelin or triptorelin. All share the same mechanism of receptor down‑regulation, but differences may exist in dosing frequency, formulation, and manufacturer‑specific excipients, which can influence convenience and supply chain considerations.

Leuprorelin Zentiva should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations. Do not freeze the medication.

Leuprorelin Zentiva is administered by subcutaneous injection, typically performed by a healthcare professional. The injection site is usually the abdomen or thigh, and the exact technique and frequency are outlined in the prescribing information.

Serious risks include cardiovascular events such as hypertension or myocardial infarction, significant loss of bone mineral density leading to osteoporosis or fractures, and rare severe allergic reactions like anaphylaxis. Patients should be monitored regularly for these complications.

Leuprorelin Zentiva should be avoided in individuals with known hypersensitivity to leuprorelin or any formulation components, in pregnant or nursing women, and in patients with uncontrolled cardiovascular disease unless the benefits outweigh the risks as assessed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Leuprorelin Acetate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT